THERAPY OF ADVANCED BLADDER CANCER BY TARGETING HYAL2 WITH ANTIBODY-DRUG CONJUGATE: PRECLINICAL STUDY

被引：0
|
作者：
O'Malley, Padraic
Donelan, William
Hsieh, Meng-Lun
Li, Shiwu
Nguyen, Brianna
Crispen, Paul
Kusmartsev, Sergei
机构：
来源：
JOURNAL OF UROLOGY | 2024年 / 211卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
MP65-19
引用
收藏
页码：E1084 / E1084
页数：1
相关论文
共 50 条
  • [21] CLINICAL APPLICATION OF MONOCLONAL ANTIBODY-DRUG CONJUGATE TO IMMUNOTARGETING CHEMOTHERAPY OF BLADDER CANCER
    李龙承
    章咏裳
    林乔
    李川江
    何敏
    Chinese Medical Journal, 1995, (10) : 764 - 768
  • [22] Pharmacist Involvement in Antibody-Drug Conjugate Therapy
    Mishiyeva, Oksana
    Farina, Kyle A.
    Rattu, Mohammad A.
    US PHARMACIST, 2022, 47 (01) : 34 - 55
  • [23] Novel targets for antibody-drug conjugate therapy
    Grandi, A. G.
    Campagnoli, S. C.
    Parri, M. P.
    De Camilli, E. D. C.
    Jin, B. J.
    Sarmientos, P. S.
    Grandi, G. G.
    Terracciano, L. T.
    Pileri, P. P.
    Viale, G. V.
    Grifantini, R.
    EUROPEAN JOURNAL OF CANCER, 2014, 50 : 41 - 41
  • [24] Preclinical studies of an anti-HER2 antibody-drug conjugate.
    Koeppen, H
    Dugger, D
    Tibbitts, J
    Leipold, D
    Reynolds, T
    Leach, W
    Slikowski, M
    CLINICAL CANCER RESEARCH, 2005, 11 (24) : 8980S - 8980S
  • [25] Orexin 2 receptor as a potential target for immunotoxin and antibody-drug conjugate cancer therapy
    Kishida, Masato
    Ishige, Kazunori
    Horibe, Tomohisa
    Tada, Noriko
    Koibuchi, Nobutaka
    Shoda, Junichi
    Kita, Kiyoshi
    Kawakami, Koji
    ONCOLOGY LETTERS, 2012, 3 (03) : 525 - 529
  • [26] Advanced solid cancer therapy with a novel antibody-drug conjugate (ADC), sacituzumab govitecan (IMMU-132): key preclinical and clinical results
    Starodub, Alexander N.
    Ocean, Allyson J.
    Bardia, Aditya
    Guarino, Michael J.
    Messersmith, Wells
    Berlin, Jordan
    Picozzi, Vincent J.
    Thomas, Sajeve S.
    Masters, Gregory
    Vandat, Linda T.
    Mayer, Ingrid A.
    Moroose, Rebecca
    Diamond, Jennifer S.
    Tagawa, Scott T.
    Shah, Manish A.
    Wilhelm, Francois
    Wegener, William A.
    Maliakal, Pius
    Sharkey, Robert M.
    Goldenberg, David M.
    CANCER RESEARCH, 2015, 75
  • [27] Antibody-Drug Conjugates in Bladder Cancer
    Vlachostergios, Panagiotis J.
    Jakubowski, Christopher D.
    Niaz, Muhammad J.
    Lee, Aileen
    Thomas, Charlene
    Hackett, Amy L.
    Patel, Priyanka
    Rashid, Naureen
    Tagawa, Scott T.
    BLADDER CANCER, 2018, 4 (03) : 247 - 259
  • [28] A Novel c-MET-Targeting Antibody-Drug Conjugate for Pancreatic Cancer
    Jin, Yangbing
    Zhang, Zehui
    Zou, Siyi
    Li, Fanlu
    Chen, Hao
    Peng, Chenghong
    Deng, Xiaxing
    Wen, Chenlei
    Shen, Baiyong
    Zhan, Qian
    FRONTIERS IN ONCOLOGY, 2021, 11
  • [29] A MET Targeting Antibody-Drug Conjugate Overcomes Gemcitabine Resistance in Pancreatic Cancer
    Cazes, Alex
    Betancourt, Oscar
    Esparza, Edgar
    Mose, Evangeline S.
    Jaquish, Dawn
    Wong, Eric
    Wascher, Alexis A.
    Tiriac, Herve
    Gymnopoulos, Marco
    Lowy, Andrew M.
    CLINICAL CANCER RESEARCH, 2021, 27 (07) : 2100 - 2110
  • [30] Computational Approaches in Antibody-drug Conjugate Optimization for Targeted Cancer Therapy
    Melo, Rita
    Lemos, Agostinho
    Preto, Antonio J.
    Almeida, Jose G.
    Correia, Joao D. G.
    Sensoy, Ozge
    Moreira, Irina S.
    CURRENT TOPICS IN MEDICINAL CHEMISTRY, 2018, 18 (13) : 1091 - 1109
12345